The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOsirium Tech Regulatory News (OSI)

  • This share is currently suspended. It was suspended at a price of 2.20

Share Price Information for Osirium Tech (OSI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.20
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.00
OSI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update re proposed grant of options

18 Apr 2023 07:00

RNS Number : 5049W
Osirium Technologies PLC
18 April 2023
 

18 April 2023

 

Osirium Technologies plc

("Osirium", the "Group" or the "Company")

 

Update re proposed grant of options

 

Osirium Technologies plc (AIM: OSI), a leading vendor of cloud-based cybersecurity and IT automation software, provides an update on the proposed amendments to the Company's share option scheme to be considered at its forthcoming AGM, details of which were announced on 3 April 2023 (the "Announcement").

 

The Company has received feedback from certain key shareholders in the Company ("Shareholders") regarding the proposed New Options set out in the Announcement. The Company intends to continue to seek shareholder approval for the amendments to the Company's Enterprise Management Incentive (EMI) Share Option Plan 2020-2025 (the "Plan") at the AGM as set out in the AGM notice. However, Osirium's Remuneration Committee (the "Remuneration Committee") has taken on board the feedback received and has decided to make certain amendments to the New Options proposed to be granted, should the Plan Resolution be passed at the AGM, as follows:

 

· the New Options will have a minimum exercise price of 2p (being the issue price of the Company's most recent fundraise) or, if higher at the time of grant, the 'Market Price' of an Ordinary Share as determined under the Plan rules;

 

· all New Options will be subject to the following additional performance based vesting criteria:

the closing share price of an Ordinary Share must exceed 4p for a rolling 30-day period; and

the Company must have achieved annualised recurring revenue ("ARR") of at least £3.5 million, when reported in the Company's full year or half year results.

 

· The New Options would still vest equally over three years as set out in the Announcement.

 

The Remuneration Committee believes that these additional performance criteria more closely align the targets with the interests of Shareholders. 

 

The Remuneration Committee has also determined that the New Options would only be granted to members of the full-time executive management team and key employees. Therefore, the number of New Options that are proposed to be granted to Directors of the Company and persons closely associated with them ("PCAs") are as follows:

 

Director/PCA

No. of existing options currently held and to be surrendered

No. of New Options to be granted

Percentage of existing issued share capital of the Company represented by the New Options

Stuart McGregor (CEO)

218,500

3,676,461

3.00%

Rupert Hutton (CFO)

147,250

1,225,487

1.00%

David Guyatt (Chairman)

1,061,416

-

-

Simon Lee (NED)

147,250

-

-

Simon Hember (NED)

26,125

-

-

Catherine Jamieson

(wife of David Guyatt)

180,000

612,743

0.50%

 

The Board of Osirium welcomes the opportunity for engagement with Shareholders and would like to thank those Shareholders who provided feedback on the original proposals. Full details of the proposed amendments to the Plan are set out in the explanatory notes to the notice of AGM. Should the Plan Resolution not be passed at the AGM, the Company will not be able to make the proposed amendments to the Plan or grant the New Options. A further announcement will be made on conclusion of the AGM.

 

Definitions

 

Capitalised terms used in this announcement have the meanings given to them in the Announcement issued by the Company on 3 April 2023, unless otherwise defined herein.

 

Contacts:

Osirium Technologies plc

Tel: +44 (0)1183 242 444

Stuart McGregor, Chief Executive Officer

Rupert Hutton, Chief Financial Officer

Allenby Capital Limited (Nominated adviser and broker)

Tel: +44 (0)20 3328 5656

James Reeve / George Payne (Corporate Finance)

Tony Quirke (Sales and Corporate Broking)

Alma PR (Financial PR adviser)

Tel: +44 (0)20 3405 0205

Hilary Buchanan

osirium@almapr.co.uk

Kieran Breheny

Will Ellis Hancock

 

About Osirium Technologies Plc

 

Osirium Technologies plc (AIM: OSI) is a leading UK-based cybersecurity software vendor delivering Privileged Access Management (PAM), Privileged Endpoint Management (PEM) and Osirium Automation solutions that are uniquely simple to deploy and maintain.

 

With privileged credentials involved in over 80% of security breaches, customers rely on Osirium PAM's innovative technology to secure their critical infrastructure by controlling 3rd party access, protecting against insider threats, and demonstrating rigorous compliance. Osirium Automation delivers time and cost savings by automating complex, multi-system processes securely, allowing them to be delegated to Help Desk engineers or end-users and to free up specialist IT resources. The Osirium PEM solution balances security and productivity by removing risky local administrator rights from users, while at the same time allowing escalated privileges for specific applications.

 

Founded in 2008 and with its headquarters in Reading, UK, the Group was admitted to trading on AIM in April 2016. For further information please visit www.osirium.com.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCKDLFFXZLEBBE
Date   Source Headline
1st Nov 202211:00 amRNSPrice Monitoring Extension
1st Nov 20227:00 amRNSQ3 2022 trading update
23rd Sep 202211:06 amRNSSecond Price Monitoring Extn
23rd Sep 202211:00 amRNSPrice Monitoring Extension
22nd Sep 20222:05 pmRNSSecond Price Monitoring Extn
22nd Sep 20222:00 pmRNSPrice Monitoring Extension
22nd Sep 20227:00 amRNSInterim Results
20th Sep 20227:00 amRNSSignificant contract extension
12th Sep 20227:00 amRNSNotice of Results
3rd Aug 20227:00 amRNSSignificant contract extension
21st Jul 20227:00 amRNSContract Win
8th Jul 20227:00 amRNSTrading Update
8th Jun 20224:40 pmRNSSecond Price Monitoring Extn
8th Jun 20224:35 pmRNSPrice Monitoring Extension
7th Jun 20221:02 pmRNSResult of AGM
30th May 20227:00 amRNSContract win for PEM solution
17th May 20227:00 amRNSFirst contract win in the United States
11th May 20227:00 amRNSReport and Accounts and Notice of AGM
5th May 20224:41 pmRNSSecond Price Monitoring Extn
5th May 20224:36 pmRNSPrice Monitoring Extension
27th Apr 20224:41 pmRNSSecond Price Monitoring Extn
27th Apr 20224:36 pmRNSPrice Monitoring Extension
25th Apr 20224:41 pmRNSSecond Price Monitoring Extn
25th Apr 20224:35 pmRNSPrice Monitoring Extension
21st Apr 202211:05 amRNSSecond Price Monitoring Extn
21st Apr 202211:00 amRNSPrice Monitoring Extension
21st Apr 20227:00 amRNSFinal Results
8th Apr 20222:06 pmRNSSecond Price Monitoring Extn
8th Apr 20222:00 pmRNSPrice Monitoring Extension
7th Apr 20222:05 pmRNSSecond Price Monitoring Extn
7th Apr 20222:00 pmRNSPrice Monitoring Extension
7th Apr 20229:00 amRNSPrice Monitoring Extension
6th Apr 20222:06 pmRNSSecond Price Monitoring Extn
6th Apr 20222:01 pmRNSPrice Monitoring Extension
6th Apr 202211:05 amRNSSecond Price Monitoring Extn
6th Apr 202211:00 amRNSPrice Monitoring Extension
5th Apr 20224:41 pmRNSSecond Price Monitoring Extn
5th Apr 20224:36 pmRNSPrice Monitoring Extension
5th Apr 20222:06 pmRNSSecond Price Monitoring Extn
5th Apr 20222:00 pmRNSPrice Monitoring Extension
5th Apr 202211:05 amRNSSecond Price Monitoring Extn
5th Apr 202211:00 amRNSPrice Monitoring Extension
5th Apr 20227:00 amRNSQ1 2022 Trading Update
1st Apr 20224:57 pmRNSHolding(s) in Company
31st Mar 20225:00 pmRNSTotal Voting Rights
25th Mar 20222:05 pmRNSSecond Price Monitoring Extn
25th Mar 20222:00 pmRNSPrice Monitoring Extension
24th Mar 20222:05 pmRNSSecond Price Monitoring Extn
24th Mar 20222:00 pmRNSPrice Monitoring Extension
24th Mar 20227:00 amRNSContract win for Privileged Process Automation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.